Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16004875 | 1.00 | DNM1 (0.47) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL10441897 | 1.00 | DNM1 (0.47) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL31253233 | 1.00 | DNM1 (0.47) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL409835 | 1.00 | DNM1 (0.47) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL4244542 | 1.00 | DNM1 (0.47) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL10441645 | 1.00 | DNM1 (0.47) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL4248716 | 1.00 | DNM1 (0.47) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL10379772 | 0.98 | DNM1 (0.43) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL1835984 | 0.91 | TSHR (0.42) | DNM1HTTMEN1KMT2ATHRB | |
| SCHEMBL5415141 | 0.89 | ALDH1A1 (0.54) | ALDH1A1LPAR1LPAR3LPAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090130029-A1 | GLYCEROL ETHERS VEHICLE AND PHARMACEUTICAL COMPOSITIONS THEREOF | FOAMIX LTD. (IL) | 2009-05-21 | — | — | US | disclosed |
| US-7196052-B2 | Fragrance composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2007-03-27 | — | — | US | disclosed |
| US-20030216283-A1 | Fragrance composition | TAKASAGO INTERNATIONAL CORPORATION | 2003-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030216283-A1 | Fragrance composition | FAAH2, FAAH, DGAT1 | DNM1 3514/4885HTT 4151/4885MEN1 3931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.